Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
European Journal of Medicinal Chemistry|January 15, 2018
Synthesis and bioevaluation and doking study of 1H-pyrrolo[2,3-b]pyridine derivatives bearing aromatic hydrazone moiety as c-Met inhibitorsWenhui Wang, Shan Xu, Yongli Duan, et al.
European Journal of Medicinal Chemistry|February 10, 2015
Design, synthesis and docking studies of novel thienopyrimidine derivatives bearing chromone moiety as mTOR/PI3Kα inhibitorsWufu Zhu, Chen Chen, Chengyu Sun, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 23, 2024
In silico method and bioactivity evaluation to discover novel antimicrobial agents targeting FtsZ protein: Machine learning, virtual screening and antibacterial mechanism studyLinxiao Wang, Zhouling Xie, Wei Ruan, et al.
Bioorganic Chemistry|May 1, 2024
Design, synthesis, and evaluation of antitumor activity of Mobocertinib derivatives, a third-generation EGFR inhibitorDang Fan, Han Zhang, Lei Duan, et al.
European Journal of Medicinal Chemistry|April 14, 2026
Discovery of novel bis-aryl urea-linked triazine derivatives as dual PI3K/mTOR inhibitors via scaffold hopping strategy and biological activity evaluationsZhenjie Cheng, Yang Yang, Rujue Peng, et al.
Nanomedicine (London, England)|March 28, 2026
Smart oral delivery of curcumin nanoparticulate systems for targeted colorectal cancer therapy: strategies, applications, and future perspectivesYuxuan Zhu, Tianyu Wu, Yuxing Fu, et al.
Bioorganic & Medicinal Chemistry|September 21, 2017
Design, synthesis and antitumor activity of Novel Sorafenib derivatives bearing pyrazole scaffoldMin Wang, Shan Xu, Huajun Lei, et al.
Bioorganic & Medicinal Chemistry|April 22, 2017
Design, synthesis, and docking studies of quinazoline analogues bearing aryl semicarbazone scaffolds as potent EGFR inhibitorsYuanbiao Tu, Caolin Wang, Shan Xu, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2016
Design, synthesis and activity of novel sorafenib analogues bearing chalcone unitMin Wang, Shan Xu, Chunjiang Wu, et al.
European Journal of Medicinal Chemistry|November 5, 2019
Design, synthesis and 3D-QSAR analysis of novel thiopyranopyrimidine derivatives as potential antitumor agents inhibiting A549 and Hela cancer cellsBingbing Zhao, Chengwu Zhao, Xiaohan Hu, et al.
Pageof 9